Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Statistics in Medicine|January 10, 2002
Accounting for correlation and compliance in cluster randomized trialsT Loeys, S Vansteelandt, E GoetghebeurBiometrics|May 24, 2003
A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing complianceT Loeys, E GoetghebeurStatistics in Medicine|July 12, 2002
Baseline information in structural failure time estimators for the effect of observed treatment complianceT Loeys, E GoetghebeurStatistics in Medicine|October 30, 2004
Sense and sensitivity when correcting for observed exposures in randomized clinical trialsS Vansteelandt, E GoetghebeurLifetime Data Analysis|December 6, 2005
Causal proportional hazards models and time-constant exposure in randomized clinical trialsT Loeys, E Goetghebeur, A VandeboschStatistics in Medicine|January 11, 2017
Boosting the precision of mediation analyses of randomised experiments through covariate adjustmentS Vandenberghe, S Vansteelandt, T LoeysBiometrics|December 29, 2000
Regression models for disease prevalence with diagnostic tests on pools of serum samplesS Vansteelandt, E Goetghebeur, T VerstraetenLifetime Data Analysis|June 14, 2000
Vitamin A and infant mortality: beyond intention-to-treat in a randomized trialP Korhonen, T Loeys, E Goetghebeur, et al.Biostatistics (Oxford, England)|March 20, 2008
Optimal screening for promising genes in 2-stage designsB Moerkerke, E GoetghebeurJournal of Computational Biology : a Journal of Computational Molecular Cell Biology|December 7, 2006
Selecting "significant" differentially expressed genes from the combined perspective of the null and the alternativeB Moerkerke, E GoetghebeurPageof 5